Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Xipamid
1. 14293-44-8
2. 4-chloro-n-(2,6-dimethylphenyl)-2-hydroxy-5-sulfamoylbenzamide
3. Diurexan
4. Xipamid
5. Aquaphor
6. Diurex (lacer)
7. Aquaphor (diuretic)
8. Mjf 10,938
9. Be 1293
10. 4-chloro-5-sulfamoyl-2',6'-salicyloxylidide
11. Mjf-10938
12. Benzamide, 5-(aminosulfonyl)-4-chloro-n-(2,6-dimethylphenyl)-2-hydroxy-
13. Be-1293
14. 4s9ey0nuec
15. 2',6'-salicyloxylidide, 4-chloro-5-sulfamoyl-
16. 4-chlor-5-sulfamoyl-2',6'-salicyloxylidid
17. Xipamide (usan)
18. Ncgc00182543-01
19. Aquaphoril
20. Xipamide [usan]
21. Zipix
22. Aquaphor(tm), Original Formula Ointment Base
23. Dsstox_cid_3744
24. Dsstox_rid_77179
25. Dsstox_gsid_23744
26. Chronexan
27. Xipamida
28. Xipamidum
29. Xipamidum [inn-latin]
30. Xipamida [inn-spanish]
31. Xipamide [usan:inn:ban]
32. Cas-14293-44-8
33. Einecs 238-216-4
34. Unii-4s9ey0nuec
35. Mjf 10938
36. Brn 2778357
37. Lumitens
38. 4-chlor-5-sulfamoyl-2',6'-salicyloxylidid [german]
39. Xipamide [inn]
40. Xipamide [mi]
41. Xipamide [mart.]
42. Xipamide [who-dd]
43. Schembl43532
44. Chembl517199
45. Gtpl7900
46. Dtxsid5023744
47. Chebi:135499
48. Zinc538538
49. 4-chloro-n-(2,6-dimethylphenyl)-2-hydroxy-5-sulfamoyl-benzamide
50. Bei-1293
51. Tox21_112975
52. 5-(aminosulfonyl)-4-chloro-n-(2,6-dimethylphenyl)-2-hydroxybenzamide
53. Ac-911
54. Mfcd00865927
55. S5076
56. Akos015889012
57. Tox21_112975_1
58. Ccg-268092
59. Cs-w023041
60. Db13803
61. Ds-1401
62. Hy-w042301
63. Ncgc00182543-02
64. Ft-0659690
65. Ft-0675876
66. X0079
67. 4-chloro-5-sulfamoyl-2',6'-salicyloxilidide
68. 4-chloro-5-sulfamoyl-2?,6?-salicyloxylidide
69. D06341
70. 293x448
71. A807988
72. Q600951
73. Q-201936
74. 4-chloro-n-(2,6-dimethylphenyl)-2-hydroxy-5-sulphamoylbenzamide
75. 4-chloro-n-(2,6-dimethylphenyl)-2-hydroxy-5-sulfamoyl-benzamide;xipamide
76. 5-(aminosulfonyl)-4-chloro-n-(2,6-dimethylphenyl)-2-hydroxy-benzamide
77. 5-(aminosulfonyl)-4-chloro-n-(2,6-dimethylphenyl)-2-hydroxybenzamide #
78. Benzamide,5-(aminosulfonyl)-4-chloro-n-(2,6-dimethylphenyl)-2-hydroxy-
Molecular Weight | 354.8 g/mol |
---|---|
Molecular Formula | C15H15ClN2O4S |
XLogP3 | 2.9 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 3 |
Exact Mass | 354.0441058 g/mol |
Monoisotopic Mass | 354.0441058 g/mol |
Topological Polar Surface Area | 118 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 526 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Diuretics
Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
C - Cardiovascular system
C03 - Diuretics
C03B - Low-ceiling diuretics, excl. thiazides
C03BA - Sulfonamides, plain
C03BA10 - Xipamide
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?